Distribution · GCC · Announced 21 Jul 2026
Itqan Pharmaceuticals → Address Healthcare
Distribution deal between Itqan Pharmaceuticals (Jordan) and Address Healthcare (Saudi Arabia), announced 21 Jul 2026. Value: Undisclosed.
Parties: ITQAN PHARMACEUTICALS (Jordan) → Address Healthcare (Saudi Arabia)
- Deal type
- Distribution
- Value
- Undisclosed
- Territory
- Saudi Arabia
- Therapeutic area
- Other
- Asset
- Itqan's pharmaceutical product portfolio (specific products/therapeutic areas not disclosed)
- Announced
- 21 Jul 2026
Our analysis
Why this matters — for Itqan, it's a second GCC door.
Per our tracker, Itqan's only prior GCC presence was Oman . Saudi Arabia — the largest pharma market in the region by a wide margin — is the prize, and also the hardest to enter: it demands local registration, SFDA-licensed warehousing, and an in-market commercial engine. Rather than build that itself, Itqan is renting it. This partnership hands Itqan a ready-made Saudi channel, taking it from a one-market Gulf footprint (Oman) toward the market that actually moves the needle.
The full analysis is free to read with a work email on this page.
Source: Itqan Pharmaceutical Industries announcement (LinkedIn)